Novartis AG (NVS)
NYSE: NVS · IEX Real-Time Price · USD
97.44
-1.62 (-1.64%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Novartis AG Revenue

Novartis AG had revenue of $49.92B in the twelve months ending March 31, 2024, with 8.81% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $12.12B with 9.71% year-over-year growth. In the year 2023, Novartis AG had annual revenue of $46.66B with 7.36% growth.

Revenue (ttm)
$49.92B
Revenue Growth
+8.81%
P/S Ratio
3.82
Revenue / Employee
$656,402
Employees
76,057
Market Cap
190.64B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 201948.68B2.58B5.59%
Dec 31, 201846.10B2.70B6.21%
Dec 31, 201743.40B-6.03B-12.20%
Dec 31, 201649.44B-951.00M-1.89%
Dec 31, 201550.39B-3.25B-6.05%
Dec 31, 201453.63B918.00M1.74%
Dec 31, 201352.72B745.00M1.43%
Dec 31, 201251.97B-7.40B-12.47%
Dec 31, 201159.38B7.81B15.15%
Dec 31, 201051.56B6.46B14.32%
Dec 31, 200945.10B2.52B5.92%
Dec 31, 200842.58B3.64B9.34%
Dec 31, 200738.95B3.84B10.94%
Dec 31, 200635.11B5.35B17.99%
Dec 31, 200529.75B2.48B9.08%
Dec 31, 200427.28B2.35B9.41%
Dec 31, 200324.93B4.05B19.41%
Dec 31, 200220.88B2.12B11.27%
Dec 31, 200118.76B-3.07B-14.06%
Dec 31, 200021.83B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 85.16B
Merck & Co. 60.12B
Pfizer 58.50B
AbbVie 54.32B
AstraZeneca 47.61B
Thermo Fisher 42.86B
Abbott Laboratories 40.11B
Amgen 28.19B
Revenue Rankings